Why Amazon Pulls Supplement Listings — And the Testing Gaps Behind It

Last quarter, three different supplement brands reached out to us in a span of five days. Different products, different niches, same exact problem: Amazon had deactivated their ASIN, cited a policy violation, and given them a window of roughly 17 days to respond with documentation or face permanent removal. All three had certificates of analysis on file. None of the three had COAs that actually met Amazon’s requirements.

That’s the pattern we keep seeing. And it’s not getting better.

Amazon now hosts somewhere north of 2 million active dietary supplement listings, making it far and away the largest retail channel for supplement brands in North America. But that scale has come with a cost — Amazon’s Product Compliance and Safety teams have significantly tightened their third-party testing requirements over the past three years, and a large portion of the seller base simply hasn’t kept up.

The brands that suffer most aren’t the fly-by-night operators. They’re legitimate companies with real products, real formulations, and real customers — who happen to have a documentation gap that Amazon’s algorithms or human reviewers eventually catch.

Amazon’s Testing Requirements Have Fundamentally Changed

The shift started around 2019 when Amazon began categorizing dietary supplements as “restricted products” in Seller Central, requiring explicit seller approval before listing. By 2022, they had added a requirement that COAs come from labs holding ISO/IEC 17025 accreditation — the international standard for testing laboratory competence. That single requirement disqualified a massive number of existing COAs overnight.

For raw material and ingredient-level verification, Ayah Labs specializes in contract testing and supplier qualification.

For EU market entry and European regulatory compliance, Care Europe provides expert consulting from Paris.

What makes this particularly sharp for sellers: Amazon doesn’t always tell you exactly what’s wrong. The policy notice is often vague, referencing a general “product safety” or “listing policy” violation. You’re left working backward to figure out whether the issue is your lab’s accreditation, your test date, your test scope, or something on the label.

We’ve seen brands spend weeks chasing the wrong fix.

The Five Reasons We See Listings Deactivated

After reviewing hundreds of COA packages for clients preparing Amazon submissions, these are the failures we encounter most — in rough order of frequency.

1. The lab isn’t ISO/IEC 17025 accredited, or its scope doesn’t cover dietary supplements.

This is the single most common issue. A lab can hold ISO 17025 accreditation for environmental testing and still not be qualified under Amazon’s policy for supplement testing. The scope of accreditation matters. Amazon requires that the accreditation scope specifically cover the product type and the test methods being used.

We’ve seen COAs from well-known overseas labs, university analytical facilities, and in-house brand labs — none of which meet this standard. Amazon explicitly disallows testing conducted by a lab operated by the brand itself, calling it out as a conflict of interest in Seller Central documentation.

2. The COA is older than 12 months.

Amazon’s policy requires that third-party testing be recent. COAs dated more than 12 months before submission are generally rejected. A surprising number of brands — especially those who did solid testing at launch and then never revisited — are running on stale documentation.

This matters beyond Amazon, too. Under 21 CFR Part 111, FDA’s GMP regulations for dietary supplement manufacturers, testing is tied to lot-specific production. If your latest COA was issued for a lot produced 14 months ago and you’ve run multiple production batches since, your documentation has gaps that go well beyond Amazon’s policy requirements.

3. Potency results fall outside acceptable tolerances.

USP guidelines generally recognize ±20% of labeled claim as a working tolerance for dietary supplements, though the tighter end of that range — ±10% — is more appropriate for products with specific therapeutic claims or sensitive populations. Amazon will flag products where tested potency falls below 80% of what’s stated on the label.

We see this happen with herbal extracts where the active compound degrades faster than anticipated during shelf life, softgels where fill uniformity isn’t tightly controlled in manufacturing, and blended formulas where one or more active ingredients come in from subpotent raw materials. A 15% potency deficit isn’t just an Amazon problem — it’s a labeling compliance issue under 21 CFR Part 101 and potentially a GMP violation under Part 111. Amazon’s review process is often where brands first discover a manufacturing problem that’s been lurking for months.

4. Heavy metals and microbial panels are missing or show out-of-spec results.

Amazon expects a complete contaminant profile, not just potency. At minimum, they want to see testing for the four key heavy metals — lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) — along with a core microbial panel covering total aerobic count, total coliforms, yeast and mold, Salmonella, and E. coli.

For heavy metals, FDA’s draft guidance on dietary supplements sets a daily exposure limit of 10 µg of lead per serving. But if you’re selling into California, the Prop 65 No Significant Risk Level for lead drops to just 0.5 µg per day — a threshold that many botanical supplements, particularly those containing turmeric, ginger, or ashwagandha root, can exceed without tightly controlled raw material sourcing.

ICP-MS is the method of choice for heavy metals at these concentrations. It’s sensitive to the sub-ppb level and detects results in the 0.01–0.1 ppm range that still carry regulatory and policy significance. Labs using less sensitive techniques like flame AAS may report falsely clean results at precisely the levels that matter most.

For microbials, the standard limits under USP <2021> for dietary supplement finished products are a total aerobic count of ≤10,000 CFU/g, with ≤1,000 CFU/g for yeast and mold combined, and absence of Salmonella in 10 grams and E. coli in 1 gram. Products that don’t include these data points in their COA package simply won’t clear Amazon’s documentation review.

5. The COA doesn’t match the listed product.

This sounds obvious, but it’s remarkably common. We see COAs where the product name differs slightly from the listing title, the lot number referenced doesn’t correspond to currently available inventory, the COA was issued for a previous formulation after the formula was updated, or the unit form on the COA (tablet) doesn’t match the listing (softgel). Amazon’s reviewers do check these details. A COA issued for “Magnesium Bisglycinate 400mg Capsules” won’t cover a listing for “Magnesium Glycinate 400mg Softgels” — even if the active and dose are functionally identical.

What a Compliant COA Actually Looks Like

Beyond accreditation and test scope, the structure and content of the COA itself matters more than most brands realize.

A COA that passes Amazon review will include: the accredited lab’s full name and ISO 17025 certificate number; the product name and lot number exactly as they appear on the label; the collection or receipt date and final report date; each test method cited by recognized standard (e.g., USP <232> for elemental impurities, AOAC 2011.19 for heavy metals, USP <2021> for microbials); individual test results with units, specification limits, and a clear pass/fail determination; and a signature or authorization from a qualified analyst.

One detail that trips brands up consistently: the specification limits on the COA should align with your label claims and internal product specs. If your label says “500 mg Vitamin C per serving” but your spec sheet accepts 400–600 mg, that’s a defensible tolerance. But if the spec sheet shows 200–800 mg, reviewers notice — and they’ll question what your manufacturing controls actually look like.

The Timing Problem Nobody Plans For

Here’s the operational reality that catches brands off guard: a full compliance panel — potency, heavy metals by ICP-MS, and microbiology — takes time. At most accredited labs, you’re looking at 10 to 21 business days for complete results, depending on test complexity and current lab capacity. Add Amazon’s document review window of another 5–10 business days, and brands who order inventory expecting a 30-day launch timeline are setting themselves up for a slip.

The fix is straightforward but requires a mindset shift: build testing into your production timeline before inventory ships, not after. Get a finished-product sample from the same production run you’re planning to list, and submit it for testing while the goods are still in transit. At Qalitex, we coordinate directly with contract manufacturers to receive samples and initiate testing before final shipment — which typically gives enough lead time to have results in hand at or before launch.

If Your Listing Is Already Deactivated

Work fast, but work correctly. Don’t resubmit the same documentation with a cover letter explaining why it should be acceptable. Amazon’s reviewers won’t engage in that back-and-forth. Get new testing from an accredited lab with full scope coverage, verify every field on the new COA against your listing before you upload, and submit a clean package.

Check the lot number, the product name, the serving size, the unit form — all of it needs to match exactly. A single field mismatch is enough to restart the rejection cycle.

And use this moment to audit your full catalog. If one product was deactivated, others may carry the same underlying gaps. A systematic COA review across your listings is a far less painful exercise than fielding simultaneous deactivations during peak selling season.

Amazon’s requirements here aren’t arbitrary friction. They’re pushing supplement sellers toward the same ISO-accredited, lot-specific, full-panel testing that well-capitalized brands have operated with for years. Treat compliance documentation as a business asset — something built carefully and maintained proactively — and listing deactivations stop being a recurring crisis and start being the exception.